Alnylam Pharmaceuticals
A biopharmaceutical company focusing on the discovery, development, and commercialization of RNAi therapeutics for treating rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS) diseases.
Key facts
| AngelList URL | https://angel.co/alnylam-pharmaceuticals |
|---|---|
| CAGE Code | 45SR1 |
| Legal Name | Alnylam Pharmaceuticals, Inc. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/alnylam-pharmaceuticals |
| Facebook URL | https://www.facebook.com/OUTBio/ |
| Full Address | 675 West Kendall St Cambridge, MA 02142 |
| Instagram URL | https://www.instagram.com/alnylampharma/ |
| Legal Entity Identifier | 529900S3ZI14OWRJII50 |
| LinkedIn URL | http://www.linkedin.com/company/alnylam-pharmaceuticals |
| Pitchbook URL | https://pitchbook.com/profiles/company/42020-38#overview |
| Previous Name | ALNYLAM PHARMACEUTICALS INC |
| Stock Symbol | ALNY |
| Ticker Symbol | ALNY |
| Twitter URL | https://twitter.com/Alnylam |
| Official Website | https://alnylam.com |
| Wellfound ID | alnylam-pharmaceuticals |
| Wikidata ID | Q16974682 |
| YouTube Channel | https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw |
Contact details
Email and phone for Alnylam Pharmaceuticals are available to signed-in members of PharmaLyt.
Sign in to view